HUP0300190A2 - Tricyclic compounds as hiv reverse transcriptase inhibitors and pharmaceutical compositions containing them and their preparation - Google Patents

Tricyclic compounds as hiv reverse transcriptase inhibitors and pharmaceutical compositions containing them and their preparation

Info

Publication number
HUP0300190A2
HUP0300190A2 HU0300190A HUP0300190A HUP0300190A2 HU P0300190 A2 HUP0300190 A2 HU P0300190A2 HU 0300190 A HU0300190 A HU 0300190A HU P0300190 A HUP0300190 A HU P0300190A HU P0300190 A2 HUP0300190 A2 HU P0300190A2
Authority
HU
Hungary
Prior art keywords
group
optionally substituted
alkyl
reverse transcriptase
atom
Prior art date
Application number
HU0300190A
Other languages
English (en)
Inventor
Rajagopal Bakthavatchalam
Barry L Johnson
Mona Patel
James D Rodgers
Christine M Tarby
Haisheng Wang
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of HUP0300190A2 publication Critical patent/HUP0300190A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A találmány (I) általános képletű triciklusos vegyületekre és sóikravonatkozik, amelyek HIV-reverz transzkriptáz gátlására használhatók,továbbá a vegyületeket tartalmazó gyógyászati készítményekre ésdiagnosztikai kitekre, ezek vírusos fertőzés kezelésére vagymeghatározás standardként vagy reagensként való alkalmazásáravonatkozik, ahol a képletben az A gyűrű egy vagy két nitrogénatomottartalmazó, adott esetben B csoporttal helyettesített hattagúheterogyűrű; B jelentése halogénatom, alkil-, hidroxil-, alkoxi-,alkiltio-, trifluormetil-, trifluormetoxi-, nitro-, ciano- és adottesetben helyettesített aminocsoport; W, X, Y és Z jelentésenitrogénatom vagy helyettesített -CH= csoport; R1 jelentése adottesetben halogénatommal helyettesített alkil- vagy ciklopropilcsoport;R2 jelentése adott esetben helyettesített alkil-, alkenil-, alkinil-,cikloalkil-, fenil-, adott esetben helyettesített 3-6-tagú heterociklusos rendszer, amely 1-3 heteroatomot tartalmazaz alábbiak közül választva: oxigén-, nitrogén- vagy kénatom, adottesetben helyettesített hidroxil-, metiltio- vagy aminocsoport;cianocsoport; R8 jelentése hidrogénatom, alkil-, alkoxi-, ariloxi-,arilmetil-, alkilkarboniloxialkoxi-, alkilamino-, fenilamino-,fenilalkoxi- és aminoalkilkarbonilcsoport vagy helyettesítettalkilcsoport; és n értéke 0, 1, 2, 3 vagy 4. Ó
HU0300190A 1999-10-19 2000-10-19 Tricyclic compounds as hiv reverse transcriptase inhibitors and pharmaceutical compositions containing them and their preparation HUP0300190A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16032999P 1999-10-19 1999-10-19
US22617100P 2000-08-17 2000-08-17
PCT/US2000/028824 WO2001029037A2 (en) 1999-10-19 2000-10-19 Condensed naphthyridines as hiv reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
HUP0300190A2 true HUP0300190A2 (en) 2003-05-28

Family

ID=26856799

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300190A HUP0300190A2 (en) 1999-10-19 2000-10-19 Tricyclic compounds as hiv reverse transcriptase inhibitors and pharmaceutical compositions containing them and their preparation

Country Status (19)

Country Link
US (2) US6593337B1 (hu)
EP (1) EP1222186A2 (hu)
JP (1) JP2003512375A (hu)
KR (1) KR20020079729A (hu)
CN (1) CN1409711A (hu)
AU (1) AU773309B2 (hu)
BR (1) BR0015056A (hu)
CA (1) CA2387896A1 (hu)
CZ (1) CZ20021353A3 (hu)
EA (1) EA200200471A1 (hu)
EE (1) EE200200202A (hu)
HK (1) HK1049150A1 (hu)
HU (1) HUP0300190A2 (hu)
IL (1) IL149219A0 (hu)
MX (1) MXPA02003958A (hu)
NO (1) NO20021835L (hu)
PL (1) PL355727A1 (hu)
SK (1) SK5342002A3 (hu)
WO (1) WO2001029037A2 (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200300255B (en) 2000-07-20 2004-09-28 Bristol Myers Squibb Pharma Co Tricyclic 2-pyridone compounds useful as HIV reverse transcriptase inhibitors.
US6596729B2 (en) 2000-07-20 2003-07-22 Bristol-Myers Squibb Company Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
MXPA03009482A (es) * 2001-04-19 2004-02-12 Bristol Myers Squibb Co Compuestos triciclicos utiles como inhibidores de la transcriptasa inversa del virus de inmunodeficiencia humana (vih).
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
TW200306192A (en) 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7708701B2 (en) 2002-04-19 2010-05-04 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device
US6909001B2 (en) 2002-12-12 2005-06-21 Pharmacia Corporation Method of making tricyclic aminocyanopyridine compounds
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc METHOD AND APPARATUS FOR PROVIDING IMPROVED SAMPLE CAPTURING DEVICE
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc METHOD AND APPARATUS PROVIDING A VARIABLE USER INTERFACE
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US7504969B2 (en) * 2006-07-11 2009-03-17 Data Domain, Inc. Locality-based stream segmentation for data deduplication
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
JP5643290B2 (ja) * 2009-04-09 2014-12-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｈｉｖ複製の阻害薬
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
WO2012092367A1 (en) * 2010-12-28 2012-07-05 University Of Rochester Nucleic acid binding compounds, methods of making, and use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3262294D1 (en) 1981-05-13 1985-03-28 Ici Plc Pharmaceutical compositions containing spiro succinimide derivatives
DD204480A1 (de) 1982-04-13 1983-11-30 Meisel Verfahren zur herstellung von in 10-stellung basisch substituierten 5,5-dimethyl-5,10-dihydro-benzo(b)(1,8)naphthyridinen
EP0393604B1 (en) 1989-04-20 1997-12-29 Boehringer Ingelheim Pharmaceuticals Inc. 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS
ATE116320T1 (de) 1989-04-20 1995-01-15 Boehringer Ingelheim Pharma 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin 6-one und -thione und deren verwendung bei der vorbeugung und und behandlung von aids.
US5171745A (en) 1990-07-13 1992-12-15 Du Pont Merck Pharmaceutical Company Method of treating neurological dysfunction using neutrotransmitter enhancers
US5087625A (en) 1990-10-19 1992-02-11 Boehringer Ingelheim Pharmaceuticals, Inc. Pyridodiazepines and their use in the prevention or treatment of HIV infection
IL102764A0 (en) 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
WO1993004047A1 (en) 1991-08-16 1993-03-04 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
US5527819A (en) * 1991-09-06 1996-06-18 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
HUT71132A (en) 1992-03-27 1995-11-28 Schering Corp Bis-aryl-carbinol derivatives, pharmaceutical compositions containing them and process for producing
US5665720A (en) 1992-08-07 1997-09-09 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
CA2145407C (en) 1992-09-28 2009-09-22 Louis A. Carpino New reagents for peptide couplings
US5594001A (en) 1993-04-08 1997-01-14 The Dupont Merck Pharmaceutical Company Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
DE4320347A1 (de) 1993-06-19 1994-12-22 Boehringer Mannheim Gmbh Quinazolin-Derivate und diese enthaltende Arzneimittel
WO1995012583A1 (en) 1993-11-05 1995-05-11 Merck & Co., Inc. New quinazolines as inhibitors of hiv reverse transcriptase
DE4344452A1 (de) 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
US5750528A (en) 1995-02-01 1998-05-12 The Dupont Merck Pharmaceutical Company Blockade of neuronal m-channels as a therapeutic approach to the treatment of neurological disease
WO1996031469A1 (en) 1995-04-07 1996-10-10 Novo Nordisk A/S N-substituted azaheterocyclic carboxylic acids and esters thereof
US5874430A (en) 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US6124302A (en) 1997-04-09 2000-09-26 Dupont Pharmaceuticals 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors

Also Published As

Publication number Publication date
NO20021835L (no) 2002-06-18
WO2001029037A2 (en) 2001-04-26
US20040002498A1 (en) 2004-01-01
KR20020079729A (ko) 2002-10-19
CZ20021353A3 (cs) 2002-09-11
NO20021835D0 (no) 2002-04-18
PL355727A1 (en) 2004-05-17
WO2001029037A3 (en) 2002-01-24
AU1213701A (en) 2001-04-30
SK5342002A3 (en) 2003-04-01
EP1222186A2 (en) 2002-07-17
MXPA02003958A (es) 2002-12-10
CN1409711A (zh) 2003-04-09
IL149219A0 (en) 2002-11-10
EA200200471A1 (ru) 2003-04-24
HK1049150A1 (zh) 2003-05-02
EE200200202A (et) 2003-06-16
JP2003512375A (ja) 2003-04-02
AU773309B2 (en) 2004-05-20
BR0015056A (pt) 2003-06-10
CA2387896A1 (en) 2001-04-26
US6593337B1 (en) 2003-07-15

Similar Documents

Publication Publication Date Title
HUP0300190A2 (en) Tricyclic compounds as hiv reverse transcriptase inhibitors and pharmaceutical compositions containing them and their preparation
CY1107532T1 (el) Παραγωγα ναφθυριδινης, παρασκευη και χρηση τους ως αναστολεις του ισοενζυμου 4 της φωσφοδιεστepασης (pde4)
HUP0004845A2 (hu) PPAR-gamma agonista aktivitással rendelkező szubsztituált 4-hidroxi-fenil-alkánsav-származékok és ezeket tartalmazó gyógyszerkészítmények
HUP0303729A2 (hu) Akridinszármazékok és azok gyógyszerként történő alkalmazása és eljárás az előállításukra
HUP0300416A2 (hu) Antibiotikus hatású oxazolidinon-származékok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
HUP0104646A2 (hu) Fuzionált 1,2,4-tiadiazin-származékok, azok előállítása és felhasználása
EP1381366A4 (en) INDOL, AZAINDOL AND RELATED HETEROCYCLIC AMIDOPIPERAZINE DERIVATIVES
HUP9802822A2 (hu) Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények
HUP0203450A2 (hu) Pirazolo[4,3-d]pirimidin-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
TW200512208A (en) Piperazine derivatives
HUP0204101A2 (hu) 3-Amino-kinazolin-2,4-dion antibakteriális hatóanyagok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0101031A2 (hu) Biciklo[2.2.1]heptán-származékok és rokon vegyületek
HUP0105081A2 (hu) Triazolo[4,5-d]pirimidin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0201789A2 (hu) A légzőrendszerre ható szinciciális vírus replikációját gátló vegyületek
HUP0203438A2 (hu) Foszfodiészteráz gátló hatású 5-(2-helyettesített-5-heterociklilszulfonilpirid-3-il)-dihidropirazolo[4,3-d]-pirimidin-7-on-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0400370A2 (hu) Antibakteriális hatású oxazolidinonszármazékok, előállításukra szolgáló eljárás, azokat hatóanyagként tartalmazó gyógyászati készítmények, alkalmazásuk és intermedierek
DK0759027T3 (da) Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase
SE9701304D0 (sv) Compounds
HUP0202191A2 (hu) A koagulációs kaszkád szelektív gátlására alkalmas helyettesített policiklusos aril- és heteroaril-pirazinonok, valamint az ezeket tartalmazó gyógyszerkészítmények
WO2003008412A3 (en) Hetero-bicyclic crf antagonists
HUP0400317A2 (hu) Béta-karbolin származékok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
BR0308759A (pt) Derivados de fenil amidas siliconadas utilizáveis como microbiocida
DE60201089D1 (de) 6-(2-chlor-6-fluor-phenyl)-triazolpyrimidine
TR199801648T2 (xx) Herbisid olarak pirazol-4-il-hetaroil t�revleri
ATE259359T1 (de) Benzoxazol-derivate zur verwendung als integrin- inhibitoren